DRICH1/C22orf43 anticorps (AA 1-100) (Biotin)

N° du produit ABIN1699901

Détail du produit anti-DRICH1/C22orf43 anticorps (Biotin)

Antigène: DRICH1/C22orf43 (C22orf43) (Chromosome 22 Open Reading Frame 43 (C22orf43))

Épitope: AA 1-100

Reactivité: Humain, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp DRICH1/C22orf43 est conjugé à/à la Biotin

Application: Western Blotting (WB), ELISA, Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Réactivité croisée: Humain, Rat

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human C22orf43

Isotype: IgG

Information d'application

Indications d'application: WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C for 12 months.

Date de péremption: 12 months

Détails sur DRICH1/C22orf43

Antigène: DRICH1/C22orf43 (C22orf43) (Chromosome 22 Open Reading Frame 43 (C22orf43))

Autre désignation: C22orf43 (C22orf43 Produits)

Synonymes: anticorps aspartate rich 1, anticorps DRICH1

Sujet:

Synonyms: C22orf43, Chromosome 22 open reading frame 43, CV043_HUMAN, Putative uncharacterized protein C22orf43, Uncharacterized protein C22orf43.

Background: C22orf43 (chromosome 22 open reading frame 43), also known as MGC33025 or MGC75009, is a 229 amino acid protein encoded by a gene located on human chromosome 22, which contains over 500 genes and about 49 million bases. As the second smallest human chromosome, chomosome 22 contains a wide variety of genes with numerous functions. Phelan-McDermid syndrome, Neurofibromatosis type 2 and autism are associated with chromosome 22. A schizophrenia susceptibility locus has been identified on chromosome 22 and studies show that 22q11 deletion symptoms include a high incidence of schizophrenia. Translocations between chromosomes 9 and 22 may lead to the formation of the Philadelphia Chromosome and the subsequent production of the novel fusion protein, BCR-Abl, a potent cell proliferation activator found in several types of leukemia.

ID gène: 51233